Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 4,227 | 6,151 | 1,683 | 0 | 0 |
| Cost of Goods | 4,055 | 4,329 | 1,207 | N/A | 0 |
| Gross Profit | 172 | 1,822 | 476 | N/A | 0 |
| Operating Expenses | 111,285 | 86,931 | 55,044 | 48,567 | 20,667 |
| Operating Income | -111,058 | -84,780 | -54,361 | -48,567 | -20,667 |
| Other Income | -2,484 | 2,676 | -15,992 | 488 | 104 |
| Pre-tax Income | -113,542 | -82,104 | -70,353 | -48,079 | -20,563 |
| Income Tax | N/A | N/A | -1,830 | N/A | N/A |
| Net Income Continuous | -113,542 | -82,104 | -68,523 | -48,079 | -20,563 |
| Net Income Discontinuous | -47,812 | -50,634 | N/A | N/A | N/A |
| Net Income | $-161,354 | $-132,738 | $-68,523 | $-48,079 | $-20,563 |
| EPS Basic Total Ops | -3.90 | -4.03 | -2.44 | -2.25 | -3.79 |
| EPS Basic Continuous Ops | -2.75 | -2.49 | -2.44 | -2.25 | -3.37 |
| EPS Basic Discontinuous Ops | -1.16 | -1.54 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -3.90 | -4.03 | -2.44 | -2.25 | -3.79 |
| EPS Diluted Continuous Ops | -2.75 | -2.49 | -2.44 | -2.25 | -3.37 |
| EPS Diluted Discontinuous Ops | -1.16 | -1.54 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -2.25 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-86,145 | $-82,901 | $-53,959 | $-48,447 | $-20,577 |